Literature DB >> 15663986

Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development.

Gerald R Cunha1, Will Ricke, Axel Thomson, Paul C Marker, Gail Risbridger, Simon W Hayward, Y Z Wang, Annemarie A Donjacour, Takeshi Kurita.   

Abstract

This review on normal and neoplastic growth of the prostate emphasizes the importance of epithelial-mesenchymal/stromal interactions. Accordingly, during prostatic development urogenital sinus mesenchyme (a) specifies prostatic epithelial identity, (b) induces epithelial bud formation, (c) elicits prostatic bud growth and regulates ductal branching, (d) promotes differentiation of a secretory epithelium, and (e) specifies the types of secretory proteins expressed. In reciprocal fashion, prostatic epithelium induces smooth muscle differentiation in the mesenchyme. Epithelial-mesenchymal interactions during development continue postnatally into adulthood as stromal-epithelial interactions which play a homeostatic role and in so doing reciprocally maintain epithelial and stromal differentiation and growth-quiescence. Prostatic carcinogenesis involves perturbation of these reciprocal homeostatic cell-cell interactions. The central role of mesenchyme in prostatic epithelial development has been firmly established through analysis of tissue recombinants composed of androgen-receptor-positive wild-type mesenchyme and androgen-receptor-negative epithelium. These studies revealed that at the very least ductal morphogenesis, epithelial cytodifferentiation, epithelial apoptosis and epithelial proliferation are regulated by stromal and not epithelial androgen receptors. Likewise, progression from non-tumorigenesis to tumorigenesis elicited by testosterone plus estradiol proceeds via paracrine mechanisms. Thus, stromal-epithelial interactions play critical roles in the hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15663986     DOI: 10.1016/j.jsbmb.2004.10.017

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  111 in total

1.  Soiling the seed: microenvironment and epithelial mesenchymal plasticity.

Authors:  Izhak Haviv; Erik W Thompson
Journal:  Cancer Microenviron       Date:  2012-04

2.  Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells.

Authors:  Chun-Peng Liao; Leng-Ying Chen; Andrea Luethy; Youngsoo Kim; Kian Kani; A Robert MacLeod; Mitchell E Gross
Journal:  Endocr Relat Cancer       Date:  2017-04       Impact factor: 5.678

3.  Protein kinase Cα and Src kinase support human prostate-distributed dihydrotestosterone-metabolizing UDP-glucuronosyltransferase 2B15 activity.

Authors:  Sunit K Chakraborty; Nikhil K Basu; Sirsendu Jana; Mousumi Basu; Amit Raychoudhuri; Ida S Owens
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

Review 4.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

Review 5.  Prostate stromal and urogenital sinus mesenchymal cell lines for investigations of stromal-epithelial interactions.

Authors:  Aubie Shaw; Steven Attia; Wade Bushman
Journal:  Differentiation       Date:  2008-05-07       Impact factor: 3.880

6.  The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways.

Authors:  Carlos S Moreno
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

Review 7.  Follistatin as potential therapeutic target in prostate cancer.

Authors:  Maria Vittoria Sepporta; Francesca Maria Tumminello; Carla Flandina; Marilena Crescimanno; Marco Giammanco; Maurizio La Guardia; Danila di Majo; Gaetano Leto
Journal:  Target Oncol       Date:  2013-03-01       Impact factor: 4.493

8.  Role of genetic polymorphism of estrogen receptor-alpha gene and risk of prostate cancer in north Indian population.

Authors:  Lipsy Gupta; Hitender Thakur; Ranbir C Sobti; Amlesh Seth; Sharwan K Singh
Journal:  Mol Cell Biochem       Date:  2009-11-11       Impact factor: 3.396

9.  Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor.

Authors:  Kayvan R Keshari; Renuka Sriram; Mark Van Criekinge; David M Wilson; Zhen J Wang; Daniel B Vigneron; Donna M Peehl; John Kurhanewicz
Journal:  Prostate       Date:  2013-03-26       Impact factor: 4.104

10.  The risks, degree of malignancy and clinical progression of prostate cancer associated with the MDM2 T309G polymorphism: a meta-analysis.

Authors:  Jie Yang; Wen Gao; Ning-Hong Song; Wei Wang; Jie-Xiu Zhang; Pei Lu; Li-Xin Hua; Min Gu
Journal:  Asian J Androl       Date:  2012-08-20       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.